A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
Clinical trial NCT06342349 · COMPLETED
Trial details
- NCT number
- NCT06342349
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-30
- Primary completion
- 2024-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.